Biotinylated Human IL-18BP Protein (IL8-HM4BPB)
$472.50 – $1,575.00
KACTUS Biosystems Biotinylated Human IL-18BP Protein (IL8-HM4BPB) (catalog No. IL8-HM4BPB) is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Thr31-Gly194.
- Product Details
- Description
- Additional information
- More Offers
Catalog No. | IL8-HM4BPB |
---|---|
Product Name | Biotinylated Human IL-18BP Protein (IL8-HM4BPB) |
Supplier Name | KACTUS Biosystems |
Brand Name | KACTUS Biosystems |
Synonyms | IL-18BP; Igifbp |
Species | Human |
Source | HEK293 |
Accession | O95998-2 |
Product Tag | C-His-Avi |
Biotinylated | yes |
Exact Sequence | Thr31-Gly194 |
Molecular Weight | The protein has a predicted MW of 20.5 kDa. Due to glycosylation, the protein migrates to 52-65 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Endotoxin | Less than 1EU per μg by the LAL method. |
Shipping | Shipped at ambient temperature. |
Stability & Storage | '-20 to -80°C for 12 months as supplied from date of receipt.; -20 to -80°C for 3-6 months in unopened state after reconstitution.; 2-8°C for 2-7 days after reconstitution.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
Note | Products will be shipped from the warehouse in Massachusetts. Promotion is running from time to time. Welcome to send a request for quote to message@sydlabs.com. |
Order Offline | Syd Labs, Inc. 4 Avenue E, Hopkinton, MA 01748 USA. Phone: 1-617-401-8149 Fax: 1-617-606-5019 Email: message@sydlabs.com |
Description
IL8-HM4BPB: Biotinylated Human IL-18BP Protein (IL8-HM4BPB)
Cytokines were the first modern immunotherapies to produce durable responses in patients with advanced cancer,components of the interleukin-18 (IL-18) pathway are upregulated on tumour-infiltrating lymphocytes, suggesting that IL-18 therapy could enhance anti-tumour immunity. IL-18BP, a high-affinity IL-18 decoy receptor, is frequently upregulated in diverse human and mouse tumours and limits the anti-tumour activity of IL-18 in mice.
Please remember our product information: Biotinylated Human IL-18BP Protein (IL8-HM4BPB) catalog number: IL8-HM4BPB KACTUS Biosystems
Additional information
Ship from Country | USA |
---|---|
Size | 100 ug, 500 ug |